Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001348666 | SCV001542975 | likely benign | Noonan syndrome 9 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004036561 | SCV003668823 | uncertain significance | Cardiovascular phenotype | 2022-12-15 | criteria provided, single submitter | clinical testing | The c.3644C>G (p.T1215S) alteration is located in exon 23 (coding exon 23) of the SOS2 gene. This alteration results from a C to G substitution at nucleotide position 3644, causing the threonine (T) at amino acid position 1215 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |